Company / Financials
PURE BIOSCIENCE, INC. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.2M
FY2025 · +12.4% YoY
Net Income
-$2.4M
FY2025 · +28.4% YoY
Profit Margin
-109.1%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$1.1M
FY2025
Total Debt
-
FY2025
Equity
-$5.1M
FY2025
ROA
-226.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -116.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.2M+12.4% YoYNet Income HistoryProfit after all expenses and taxes-$2.4M+28.4% YoYGross Profit HistoryRevenue minus cost of goods sold$1.3M+13.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$899.0K+10.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$2.3M+28.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.3M-18.1% YoYR&D Expense HistoryResearch and development spending$316.0K+4.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$287.0K+100.7% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$0.02+33.3% YoY